Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685010 | SCV000812478 | benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001574909 | SCV001801797 | uncertain significance | not provided | 2022-10-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002532197 | SCV003751999 | uncertain significance | Inborn genetic diseases | 2022-09-27 | criteria provided, single submitter | clinical testing | The c.2588G>A (p.G863E) alteration is located in exon 13 (coding exon 12) of the COL12A1 gene. This alteration results from a G to A substitution at nucleotide position 2588, causing the glycine (G) at amino acid position 863 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001574909 | SCV003831182 | uncertain significance | not provided | 2020-05-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003420211 | SCV004118064 | uncertain significance | COL12A1-related disorder | 2023-05-25 | criteria provided, single submitter | clinical testing | The COL12A1 c.2588G>A variant is predicted to result in the amino acid substitution p.Gly863Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.19% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-75884876-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |